{"id":"pembrolizuma","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Nausea","drugRate":"25%","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"25%","severity":"common","organSystem":""},{"effect":"Musculoskeletal pain","drugRate":"21%","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Pembrolizuma","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:17:17.872310+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:17:37.925551+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:17:30.048085+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Pembrolizuma","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:17:30.674662+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"097d166f-b73b-41d3-9b37-7653cd2a0c41","title":"KEYTRUDA QLEX (PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH) INJECTION, SOLUTION [MERCK SHARP & DOHME LLC]"},"aiSummary":"Pembrolizuma, marketed by Memorial Sloan Kettering Cancer Center, is an advanced therapy for patients with advanced or recurrent cervical cancer. The drug's key strength lies in its mechanism of action, which targets the disease effectively, positioning it as a significant player in this therapeutic area. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","ecosystem":[],"mechanism":{"target":"Programmed cell death protein 1"},"_scrapedAt":"2026-03-28T04:31:26.171Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:17:37.926627+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Advanced or recurrent cervical cancer","diseaseId":"advanced-or-recurrent-cervical-cancer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Classical Hodgkin lymphoma","diseaseId":"classical-hodgkin-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Endometrial carcinoma progressing after chemotherapy","diseaseId":"endometrial-carcinoma-progressing-after-chemotherapy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"HER2-negative breast cancer","diseaseId":"her2-negative-breast-cancer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant tumor of head and/or neck","diseaseId":"malignant-tumor-of-head-and/or-neck","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Metastatic malignant melanoma","diseaseId":"metastatic-malignant-melanoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Metastatic renal cell carcinoma","diseaseId":"metastatic-renal-cell-carcinoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Microsatellite instability-high colorectal cancer","diseaseId":"microsatellite-instability-high-colorectal-cancer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-small cell lung cancer","diseaseId":"non-small-cell-lung-cancer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Squamous cell carcinoma of esophagus","diseaseId":"squamous-cell-carcinoma-of-esophagus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Triple negative breast neoplasms","diseaseId":"triple-negative-breast-neoplasms","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Unresectable urothelial carcinoma","diseaseId":"unresectable-urothelial-carcinoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06110793","phase":"PHASE1, PHASE2","title":"A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-12-29","conditions":"Metastatic Breast Cancer","enrollment":49},{"nctId":"NCT04964479","phase":"PHASE3","title":"A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2021-08-06","conditions":"Non Small Cell Lung Cancer","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Pembrolizuma","genericName":"Pembrolizuma","companyName":"Memorial Sloan Kettering Cancer Center","companyId":"memorial-sloan-kettering-cancer-center","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:17:37.926627+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}